​

Evolent Health (EVH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

EVH Stock Forecast

Evolent Health (EVH) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $6.88, with a high of $10.00 and a low of $3.50. This represents a 83.96% increase from the last price of $3.74.

- $7 $14 $21 $28 $35 High: $10 Avg: $6.88 Low: $3.5 Last Closed Price: $3.74

EVH Stock Rating

Evolent Health stock's rating consensus is Buy, based on 29 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 21 Buy (72.41%), 8 Hold (27.59%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 29 0 8 21 Strong Sell Sell Hold Buy Strong Buy

EVH Price Target Upside V Benchmarks

TypeNameUpside
StockEvolent Health83.96%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 19.01%

Price Target Trends

1M3M12M
# Anlaysts237
Avg Price Target$7.00$6.67$6.50
Last Closing Price$3.74$3.74$3.74
Upside/Downside87.17%78.34%73.80%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26483--15
Jun, 264102--16
May, 264102--16
Apr, 264102--16
Mar, 264102--16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 21, 2026Canaccord Genuity$7.00$5.9318.04%87.17%
Jun 30, 2026Truist Financial$7.00$5.7721.32%87.17%
May 12, 2026Canaccord Genuity$6.00$3.9651.52%60.43%
Feb 25, 2026Truist Financial$6.00$3.0596.72%60.43%
Feb 25, 2026Sean DodgeBMO Capital$3.50$3.0315.51%-6.42%
Feb 02, 2026David LarsenBTIG$10.00$3.21211.53%167.38%
Dec 02, 2025Piper Sandler$6.00$3.8456.25%60.43%
Jan 16, 2025Kevin CaliendoUBS$14.00$9.9740.42%274.33%
Jan 15, 2025Jailendra SinghTruist Financial$20.00$9.97100.60%434.76%
Jan 14, 2025Sean DodgeRBC Capital$17.00$11.9642.14%354.55%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 28, 2026Cowen & Co.BuyBuyhold
Jul 23, 2026CitigroupSellNeutraldowngrade
Jul 23, 2026CitigroupBuySelldowngrade
May 15, 2026CitigroupBuyBuyhold
Mar 02, 2026Cowen & Co.BuyBuyhold
Feb 25, 2026BMO CapitalOutperformOutperformhold
Feb 02, 2026BTIGBuyBuyhold
Jan 06, 2026CitigroupOutperformOutperformhold
Jan 06, 2026CitigroupMarket OutperformMarket Outperformhold
Aug 28, 2025Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.36$-0.20$-1.28$-0.81$-5.07---
Avg Forecast$-0.04$0.86$0.78$0.72$0.78$1.08$1.09$1.52
High Forecast$-0.04$0.90$0.95$0.83$1.45$8.52$1.32$1.84
Low Forecast$-0.04$0.80$0.58$0.62$-0.19$-5.02$0.80$1.12
Surprise %800.00%-123.26%-264.10%-212.50%-750.00%---

Revenue Forecast

$500M $2B $3B $4B $5B $6B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$907.96M$1.35B$1.96B$2.55B$1.88B---
Avg Forecast$890.15M$1.34B$1.95B$2.56B$2.49B$2.85B$3.57B$4.44B
High Forecast$911.83M$1.39B$1.96B$2.97B$2.79B$2.90B$3.66B$5.16B
Low Forecast$861.35M$1.27B$1.55B$2.55B$2.00B$2.80B$3.48B$3.54B
Surprise %2.00%0.70%0.71%-0.19%-24.77%---

Net Income Forecast

$-1B $-600M $-200M $200M $600M $1B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-37.60M$-19.16M$-113.04M$-61.62M$-579.40M---
Avg Forecast$-71.64M$95.83M$-142.26M$80.93M$70.06M$20.70M$117.60M$169.10M
High Forecast$-57.31M$100.19M$-113.81M$92.64M$160.88M$947.68M$146.31M$204.65M
Low Forecast$-85.96M$89.15M$-170.71M$69.21M$-20.76M$-558.89M$88.88M$124.33M
Surprise %-47.51%-120.00%-20.54%-176.15%-926.98%---

EVH Forecast FAQ

Is Evolent Health stock a buy?

Evolent Health stock has a consensus rating of Buy, based on 29 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 21 Buy, 8 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Evolent Health is a favorable investment for most analysts.

What is Evolent Health's price target?

Evolent Health's price target, set by 29 Wall Street analysts, averages $6.88 over the next 12 months. The price target range spans from $3.5 at the low end to $10 at the high end, suggesting a potential 83.96% change from the previous closing price of $3.74.

How does Evolent Health stock forecast compare to its benchmarks?

Evolent Health's stock forecast shows a 83.96% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare information services stocks industry (19.01%).

What is the breakdown of analyst ratings for Evolent Health over the past three months?

  • July 2026: 26.67% Strong Buy, 53.33% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is Evolent Health’s EPS forecast?

Evolent Health's average annual EPS forecast for its fiscal year ending in December 2026 is $1.08, marking a -121.30% decrease from the reported $-5.07 in 2025. Estimates for the following years are $1.09 in 2027, and $1.52 in 2028.

What is Evolent Health’s revenue forecast?

Evolent Health's average annual revenue forecast for its fiscal year ending in December 2026 is $2.85B, reflecting a 51.92% increase from the reported $1.88B in 2025. The forecast for 2027 is $3.57B, and $4.44B for 2028.

What is Evolent Health’s net income forecast?

Evolent Health's net income forecast for the fiscal year ending in December 2026 stands at $20.7M, representing a -103.57% decrease from the reported $-579M in 2025. Projections indicate $117.6M in 2027, and $169.1M in 2028.